Cargando…
Antenatal corticosteroids for early preterm birth: implementation strategy lessons from the WHO ACTION-I trial
The WHO ACTION-I trial, the largest placebo-controlled trial on antenatal corticosteroids (ACS) efficacy and safety to date, reaffirmed the benefits of ACS on mortality reduction among early preterm newborns in low-income settings. We discuss here lessons learned from ACTION-I trial that are relevan...
Autores principales: | De Costa, Ayesha, Oladapo, Olufemi T., Gupta, Shuchita, Portela, Anayda, Vogel, Joshua P., Souza, Joao Paulo, Rao, Suman, Minckas, Nicole, Tuncalp, Özge, Bahl, Rajiv, Althabe, Fernando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798686/ https://www.ncbi.nlm.nih.gov/pubmed/36578090 http://dx.doi.org/10.1186/s12961-022-00941-z |
Ejemplares similares
-
Updated WHO recommendations on antenatal corticosteroids and tocolytic therapy for improving preterm birth outcomes
por: Vogel, Joshua P, et al.
Publicado: (2022) -
Factors influencing appropriate use of interventions for management of women experiencing preterm birth: A mixed-methods systematic review and narrative synthesis
por: Zahroh, Rana Islamiah, et al.
Publicado: (2022) -
Correction: Factors influencing appropriate use of interventions for management of women experiencing preterm birth: A mixed-methods systematic review and narrative synthesis
por: Zahroh, Rana Islamiah, et al.
Publicado: (2022) -
Cost-effectiveness of antenatal corticosteroids and tocolytic agents in the management of preterm birth: A systematic review
por: Sebastian, Elizabeth, et al.
Publicado: (2022) -
Antenatal corticosteroids for women at risk of imminent preterm birth in low-resource countries: the case for equipoise and the need for efficacy trials
por: Vogel, Joshua P, et al.
Publicado: (2017)